Global Oxytocin Injection Market, By Type (Branded, Generic), Application (Incomplete Abortion, Pregnancy loss, Bleeding Control, Parturition, Contraction Stress Test, Psychiatric Disorders, Lactation Control), Organism Type (Human, Animal), Sex (Men, Women), Route of Administration (Intranasal, Intravenously, Intramuscular), End-Users (Clinics, Hospitals, Birth Center, Mental Health Facility), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
Oxytocin Injection Market Analysis and Size
According to "National Vital Statistics Reports," which were published in February 2022, the percentage of unmarried births in 2020 varied from almost one in five in Utah (19.3%) to more than one in two in Louisiana (54.5%), Mississippi (55.8%), and New Mexico (53.2%). As a result, it is anticipated that the varying birth demographics in the various areas of North America will drive market expansion throughout the forecast period.
Data Bridge Market Research analyses that the oxytocin injection market, which was USD 1.28 billion in 2022, is expected to reach USD 2.17 billion by 2030, at a CAGR of 6.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Oxytocin Injection Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015 - 2020)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Type (Branded, Generic), Application (Incomplete Abortion, Pregnancy loss, Bleeding Control, Parturition, Contraction Stress Test, Psychiatric Disorders, Lactation Control), Organism Type (Human, Animal), Sex (Men, Women), Route of Administration (Intranasal, Intravenously, Intramuscular), End-Users (Clinics, Hospitals, Birth Center, Mental Health Facility), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Bimeda, Inc. (Ireland), Grindeks (Latvia), KAPL (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), AnkeBio Co., Ltd (China), Aspen Veterinary Resources, LTD (U.S.), Hemmo Pharmaceuticals Pvt Ltd (India), Shenzhen JYMed Technology Co., Ltd (China), Systacare Remedies (U.S.), AdvaCare Pharma (India), Sundent Pharm Group (Netherlands), Fresenius Kabi USA (U.S.), SAINTROY LIFESCIENCE (India), Sri Pharmacare (India)
Oxytocin injection is used to initiate or intensify labor contractions. Oxytocin is also used to lessen postpartum hemorrhage. Moreover, it could be combined with other treatments or drugs to end a pregnancy. Since oxytocin is commonly used for parturition and lactation, it is also used for abrupt deliveries. It is possible to administer oxytocin injections intravenously, intramuscularly, and intranasal.
Oxytocin Injection Market Dynamics
- Rising birth rates will propel the market growth
Global birth rates are rising, more pregnancies are ending in problems, and people are becoming more aware of induced labor and nursing. For instance, the United Nations International Children's Emergency Fund (UNICEF) reported in its December 2021 update that an anticipated 140 million children were born in 2021. In addition, the International Institute for Sustainable Development's August 2021 report projects that by 2050, there will be 9.7 billion people on the planet. This amount indicates an increase of over 24% from 2020. Since oxytocin is recommended for antepartum and postpartum pregnancies, there is a significant likelihood that the market for this injection will expand due to the increased birth rate and population.
- Innovations related to oxytocin injections will drive the market growth
Oxytocin-related innovations and joint ventures contribute to the market's expansion. For instance, according to the January 2021 update, Tonix Pharmaceuticals and Katana Pharmaceuticals have a licensing deal for Tonix's intranasal potentiated oxytocin. This will increase drug usage in metabolic disorders, particularly insulin resistance, diabetes, and obesity. Preclinical data show the efficacy of the intranasal oxytocin product TNX-1900 in central nervous system disorders, with migraine chosen by Tonix as the lead indication. The licensing agreement adds to the company's initial purchase of oxytocin-potentiated therapy from Trigemina in June 2020. These oxytocin-related joint ventures and alliances pave the way for several indications, fostering the market's expansion during the forecast period.
- The rising use of oxytocin in the area of pregnancy will act as an opportunity
The use of oxytocin in the area of pregnancy aids market expansion. For instance, according to the article titled "Role of Oxytocin in Prevention of Postpartum Hemorrhage in Unplanned Out-of-Hospital Deliveries Treated by Emergency Medical Services," published in July 2020, in Finland, postpartum hemorrhage following unplanned out-of-hospital deliveries was prevented by administering intramuscular or intravenous oxytocin. The primary factors influencing the growth of the oxytocin injection market include rising disposable incomes, particularly in developing nations, rising awareness among women about pregnancy care products, an increase in women's literacy rates, and an increase in the number of well-developed distribution channels for oxytocin products. These are certain factors that act as an immense opportunity.
- Side effects associated with oxytocin injection
Side effects associated with oxytocin injection include fast, slow, or blurred vision, uneven heart rate, severe headache, excessive bleeding long after childbirth, pounding in your neck or ears or confusion, severe weakness, and feeling unsteady. These all hamper the market growth.
This oxytocin injection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oxytocin injection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In 2020 Iptacopan (LNP023) announced PRIME designation from the European Medicines Agency (EMA), according to a statement released by Novartis today (C3G). The EMA started the PRIME program to increase funding for creating drugs that address unmet medical needs.
Global Oxytocin Injection Market Scope
The oxytocin injection market is segmented on the basis of type, application, organism type, sex, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Incomplete Abortion
- Pregnancy loss
- Bleeding Control
- Contraction Stress Test
- Psychatric Disorders
- Lactation Control
Route of Administration
- Birth Center
- Mental Health Facility
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Oxytocin Injection Market Regional Analysis/Insights
The oxytocin injection market is analysed and market size insights and trends are provided by country, type, application, organism type, sex, route of administration, end-users and distribution channel as referenced above.
The countries covered in the oxytocin injection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the oxytocin injection market due to the high cost of healthcare and favorable reimbursement regulations for oxytocin injections.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the steady rise in the number of births and women's growing understanding of reproductive health.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Oxytocin Injection Market Share Analysis
The oxytocin injection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oxytocin injection market.
Some of the major players operating in the oxytocin injection market are:
- Bimeda, Inc. (Ireland)
- Grindeks (Latvia)
- KAPL (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- AnkeBio Co., Ltd (China)
- Aspen Veterinary Resources, LTD (U.S.)
- Hemmo Pharmaceuticals Pvt Ltd (India)
- Shenzhen JYMed Technology Co., Ltd (China)
- Systacare Remedies (U.S.)
- AdvaCare Pharma (India)
- Sundent Pharm Group (Netherlands)
- Fresenius Kabi USA (U.S.)
- SAINTROY LIFESCIENCE (India)
- Sri Pharmacare (India)